Compositions and methods for TTR gene editing and treating ATTR amyloidosis
MY214783AActive Publication Date: 2026-08-17INTELLIA THERAPEUTICS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MYPI2024002117
- Authority / Receiving Office
- MY · MY
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2018-09-28
- Filing Date
- 2018-09-28
- Publication Date
- 2026-08-17
- Estimated Expiration
- 2038-09-28
Abstract
Compositions and methods for editing, e.g., introducing double-stranded breaks, within the TTR gene are provided. Compositions and methods for treating subjects having amyloidosis associated with transthyretin (ATTR), are provided.
Need to check novelty before this filing date? Find Prior Art